CYH vs. LXEO, CDNA, LFMD, PEPG, OCGN, OSUR, ADPT, ITOS, RVNC, and MXCT
Should you be buying Community Health Systems stock or one of its competitors? The main competitors of Community Health Systems include Lexeo Therapeutics (LXEO), CareDx (CDNA), LifeMD (LFMD), PepGen (PEPG), Ocugen (OCGN), OraSure Technologies (OSUR), Adaptive Biotechnologies (ADPT), iTeos Therapeutics (ITOS), Revance Therapeutics (RVNC), and MaxCyte (MXCT). These companies are all part of the "medical" sector.
Community Health Systems (NYSE:CYH) and Lexeo Therapeutics (NASDAQ:LXEO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings.
Lexeo Therapeutics has lower revenue, but higher earnings than Community Health Systems.
85.0% of Community Health Systems shares are held by institutional investors. Comparatively, 60.7% of Lexeo Therapeutics shares are held by institutional investors. 9.9% of Community Health Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Community Health Systems had 5 more articles in the media than Lexeo Therapeutics. MarketBeat recorded 20 mentions for Community Health Systems and 15 mentions for Lexeo Therapeutics. Lexeo Therapeutics' average media sentiment score of 0.47 beat Community Health Systems' score of 0.31 indicating that Lexeo Therapeutics is being referred to more favorably in the news media.
Community Health Systems currently has a consensus target price of $4.05, suggesting a potential upside of 19.47%. Lexeo Therapeutics has a consensus target price of $20.80, suggesting a potential upside of 66.40%. Given Lexeo Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Lexeo Therapeutics is more favorable than Community Health Systems.
Lexeo Therapeutics has a net margin of 0.00% compared to Community Health Systems' net margin of -0.99%. Lexeo Therapeutics' return on equity of 0.00% beat Community Health Systems' return on equity.
Community Health Systems received 539 more outperform votes than Lexeo Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Lexeo Therapeutics an outperform vote while only 53.27% of users gave Community Health Systems an outperform vote.
Summary
Lexeo Therapeutics beats Community Health Systems on 10 of the 15 factors compared between the two stocks.
Get Community Health Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CYH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Community Health Systems Competitors List
Related Companies and Tools
